Announcements Trials
Browse Landscape

Phase

Phase NA 3

Status

Recruiting 3Active not recruiting 1

Sponsor Class

OTHER 3

Study Type

Interventional 3Observational 2

Sponsor

Cancer Type

Other hematologic neoplasm 1Genitourinary 1Gastrointestinal 1

Conditions

Neoplasms 1Metastatic Hormone-Sensitive Prostate Cancer (mHSPC) 1Hematologic Neoplasms 1Gastrointestinal Neoplasms 1Anxiety Disorders 1

Interventions

pembrolizumab 553Specimen Handling 466Carboplatin 442Magnetic Resonance Spectroscopy 430Cyclophosphamide 415Cisplatin 397Radiotherapy 312Gemcitabine 309Bevacizumab 309Paclitaxel 295Biopsy 259Drug Therapy 249Capecitabine 242fludarabine 239Oxaliplatin 239Nivolumab 225venetoclax 219Injections 213Docetaxel 205Fluorouracil 203Dexamethasone 186Radiosurgery 172Rituximab 158Pemetrexed 153Standard of Care 147durvalumab 143Leucovorin 139atezolizumab 138toripalimab 134tislelizumab 134

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Recruiting × Interventional × Glutamyl Aminopeptidase × Clear all
NCT05649943 2025-09-03

APPROACH

Fondazione IRCCS Istituto Nazionale dei Tumori, Milano

Phase NA Recruiting
566 enrolled
Genitourinary

Metastatic Hormone-Sensitive Prostate Cancer (mHSPC)

NCT05441163 2025-06-24

ProActIF-01

Institut Curie

Phase NA Recruiting
50 enrolled
Gastrointestinal

Gastrointestinal Neoplasms, Neoplasms

NCT05475600 2025-03-17

APAER_H

Centre Hospitalier Régional Metz-Thionville

Phase NA Recruiting
90 enrolled
Other hematologic neoplasm

Anxiety Disorders, Hematologic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡